找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models; Hardeep Singh Tuli Book 2020 The Editor(s) (if appli

[復(fù)制鏈接]
樓主: abandon
41#
發(fā)表于 2025-3-28 16:06:57 | 只看該作者
Theorie wirtschaftspolitischer Reformen have mostly designed in a way that they can revert apoptotic abnormalities or induce apoptosis. This book chapter discusses the apoptotic process and its abnormalities in cancer cells, and how chemotherapeutic drugs can induce apoptosis, with most advanced and updated findings on mechanisms of action.
42#
發(fā)表于 2025-3-28 20:04:01 | 只看該作者
43#
發(fā)表于 2025-3-28 23:14:06 | 只看該作者
44#
發(fā)表于 2025-3-29 04:12:56 | 只看該作者
45#
發(fā)表于 2025-3-29 07:54:02 | 只看該作者
46#
發(fā)表于 2025-3-29 11:51:21 | 只看該作者
Pharmacologic Modulation of the Immune Response Against Tumours in the Elderly,the elderly, metformin and valproic acid, have been shown to have anti-neoplastic effects. These effects suggest that therapeutic approaches in the elderly should be carefully analysed. Clinical trials are required to assess the exact role of immune response and therapy in tumour incidence and survival in the elderly.
47#
發(fā)表于 2025-3-29 16:48:49 | 只看該作者
Apoptotic Cell Death: Important Cellular Process as Chemotherapeutic Target, have mostly designed in a way that they can revert apoptotic abnormalities or induce apoptosis. This book chapter discusses the apoptotic process and its abnormalities in cancer cells, and how chemotherapeutic drugs can induce apoptosis, with most advanced and updated findings on mechanisms of action.
48#
發(fā)表于 2025-3-29 22:06:19 | 只看該作者
Inflammatory Mediators: Potential Drug Targets in Cancer,ey are also found to induce inhibition of inflammation via p38/MAPK and PI3K/Akt and COX-2 activity. In the present chapter, the advancements in understanding the inflammation-mediated cancer progression and associated preclinical/clinical studies will be discussed.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 18:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
霍林郭勒市| 黄冈市| 凤台县| 蓝田县| 高阳县| 翁牛特旗| 潜江市| 洛阳市| 治县。| 玉山县| 颍上县| 北京市| 泽库县| 晴隆县| 兴城市| 区。| 平阳县| 山西省| 乌鲁木齐市| 舒城县| 会同县| 洛浦县| 淅川县| 绥江县| 本溪市| 云安县| 藁城市| 潜江市| 南丹县| 黑龙江省| 茶陵县| 铜梁县| 万荣县| 建湖县| 当雄县| 邯郸市| 德兴市| 通江县| 禄劝| 北宁市| 锡林郭勒盟|